Legislation on direct-to-consumer genetic testing in seven European countries.
about
The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposesTranslating personalized medicine using new genetic technologies in clinical practice: the ethical issuesPoints to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.Genotype-driven recruitment: a strategy whose time has come?Communication is the key. : Part 2 : Direct to consumer genetics in our future daily life ?Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation.Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in BrazilTo ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing.Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statementState of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing.Harm, hype and evidence: ELSI research and policy guidance.Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical StudiesCaptious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.Neither as harmful as feared by critics nor as empowering as promised by providers: risk information offered direct to consumer by personal genomics companies.Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport.Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics.Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study.Third party interpretation of raw genetic data: an ethical exploration.The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada.Transparency of genetic testing services for 'health, wellness and lifestyle': analysis of online prepurchase information for UK consumers.Practices and views of neurologists regarding the use of whole-genome sequencing in clinical settings: a web-based survey.Point-of-Care Diagnostics: Recent Developments in a Connected Age.Public reaction to direct-to-consumer online genetic tests: Comparing attitudes, trust and intentions across commercial and conventional providers.Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers.The challenge of personal genomics in Germany.Genetic testing for exercise prescription and injury prevention: AIS-Athlome consortium-FIMS joint statement.Direct to consumer genetic testing-law and policy concerns in Ireland.Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.A market in the making: the past, present and future of direct-to-consumer genomicsEthical, Legal and Social Issues in Japan on the Determination of Blood Relationship via DNA Testing
P2860
Q30317953-CF7A703A-01C7-45DF-941E-0CEEF2EDDB37Q34159801-D2D66C09-4152-4E4D-A5C9-688B04C079EAQ34483451-C0F8112A-9C5D-434E-B9EB-EE0F82E9D2FFQ34736416-2B4F4ADC-FB96-451B-BB54-A158F61A9979Q35333498-83EE6053-870C-4AB0-83EB-1F68A7718E80Q35460118-22B0F70A-6F43-4F9A-9C71-071B2FF577ACQ35916109-FE6C6E92-EFD6-4AFA-B5DB-832D7E5D3F39Q36205429-9FE8A7B6-391A-4474-94EE-A5F8D189D384Q36374715-E6F2F79B-022D-4A37-ABC5-CA92AB8547FFQ36551257-5F768B4C-0F84-4C19-8B16-6C8CCB14B4DCQ36998422-73E7859F-1F06-49A2-A5F4-76B640ACBD83Q36998724-819AE4A3-AA46-4663-9E4D-91E97D303FBDQ37184695-AFE0FED6-4093-45BA-9E2C-15175BDC5F3DQ37471823-548493B9-E2E0-4A8F-8675-E1A05491FF82Q37471835-FF2C5B53-90AC-4428-AC61-23D4D813D3B4Q37599537-FFB62DAA-0318-4AC4-8C40-0DEA37D805A9Q38084442-936BA513-D88B-4FDD-A8E0-CF967F1F79C1Q38548546-5C0C81DB-DD16-4BE0-9C9B-B31BD2928B5FQ38612627-952A41A4-C129-40D2-BC61-3DBE605A7C70Q38654780-7F9A8B23-E781-489C-A8A8-A7E6B3E97A62Q38681364-95244E23-1699-45D3-BF4A-64EDC1AAD277Q38685738-8D9AACB3-423F-4FCD-BF02-6498AFBDFA1BQ39037361-0870EF71-9C01-4D50-A439-7C1DD8A101AFQ39247845-5C4D3C60-D3FC-493D-8B01-D58D53EA4893Q40872861-3FD5C552-0B9E-47EE-98A3-B13BE4373AEDQ46979457-18AFEA50-68A6-44E6-A4CC-023D9B083360Q47162461-B2670977-552E-4A8A-97B6-2A1F8C83A473Q47816242-B6D8AAA5-9A77-46A1-8C98-9C805F5AED49Q49908434-78B16587-4670-4542-9923-BC6E7D61F45DQ52301800-18EB3D42-3205-4060-9428-4FBCDE7B62FFQ55344765-A68E1D30-5904-4C01-A567-BD40D4B815A4Q57780718-A87D49CC-C2C4-4F65-961C-C1147BC6DC54Q58658768-4DED1D58-9BEA-4D3A-AD6A-DF44D636A2F8
P2860
Legislation on direct-to-consumer genetic testing in seven European countries.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Legislation on direct-to-consumer genetic testing in seven European countries.
@ast
Legislation on direct-to-consumer genetic testing in seven European countries.
@en
type
label
Legislation on direct-to-consumer genetic testing in seven European countries.
@ast
Legislation on direct-to-consumer genetic testing in seven European countries.
@en
prefLabel
Legislation on direct-to-consumer genetic testing in seven European countries.
@ast
Legislation on direct-to-consumer genetic testing in seven European countries.
@en
P2093
P2860
P356
P1476
Legislation on direct-to-consumer genetic testing in seven European countries.
@en
P2093
Camilla Fittipaldi Duarte Jales
Dominique Sprumont
Emmanuelle Rial-Sebbag
Heidi Howard
Herman Nys
Liam Curren
Rachel E van Hellemondt
Tade Matthias Spranger
P2860
P2888
P304
P356
10.1038/EJHG.2011.278
P577
2012-01-25T00:00:00Z